Reenie McCarthy
Company: President & Chief Executive Officer Stealth BioTherapeutics Inc
Job title: Director
Seminars:
Elamipretide, a Mitochondrial-Targeted Drug, in the Treatment of Dry AMD 3:40 pm
Elamipretide preclinical data showed reversal of AMD pathophysiology & improvement of vision A phase 1 open label safety study of elamipretide in patients with dry AMD showed improvements in multiple measures of vision A phase 2, randomized, double-masked, placebo-controlled clinical study of elamipreide in patients with dry AMD is on-going.Read more
day: Day One
Live Presenter Q&A 5:40 pm
day: Day One